Literature DB >> 10414740

Cryosurgery for prostate cancer: improved glandular ablation by use of 6 to 8 cryoprobes.

F Lee1, D K Bahn, R A Badalament, A B Kumar, D Klionsky, G M Onik, D O Chinn, C Greene.   

Abstract

OBJECTIVES: To describe and assess the efficacy for increased glandular destruction by using 6 to 8 cryoprobes in place of the traditional 5 probes.
METHODS: In April 1996, a revised method for cryosurgery was begun that uses 6 to 8 cryoprobes, and by July 1997, 81 men had been treated. This group was compared retrospectively to our last 82 cases done before April 1996 using 5 cryoprobes. All cases were consecutive. To ensure that the groups were similar, comparison was performed of entrance prostate-specific antigen (PSA), clinical stage, and Gleason score. Six months after cryosurgery, PSA and residual epithelial acini were compared between the two groups.
RESULTS: The two groups were comparable for all the above parameters (P >0.05). The degree of overall glandular kill was greater for the 6 to 8-probe method (P = 0.023). Complete glandular ablation for the 5-probe and 6 to 8-probe methods was 39% and 53%, respectively, and the difference was not significant (P = 0.072). However, when one combined the complete glandular ablation group with the none to few residual acini group, 67.5% for the 5-probe method and 88.9% for the 6 to 8-probe method, a significant difference was found (P = 0.001). The odds of having many remaining acini versus having none to few were 3.5 times greater in the 5-probe group than in the 6 to 8-probe group. The mean and median PSA for the 5- and 6 to 8-probe groups were 0.19 and 0.1 versus 0.11 and 0.07 ng/mL, respectively, a significant difference (P = 0.02). No difference was found in rates of tumor persistence or complications.
CONCLUSIONS: A revised method for cryosurgery using 6 to 8 cryoprobes has proved to be more effective for near-glandular ablation than the traditional 5-probe method. It was easily applied, had a wide margin of safety, and even shortened learning time. These innovations have permitted a closer approach to the goal of complete glandular destruction.

Entities:  

Mesh:

Year:  1999        PMID: 10414740     DOI: 10.1016/s0090-4295(99)00039-4

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  3 in total

Review 1.  Cryotherapy.

Authors:  Katsuto Shinohara
Journal:  Int J Clin Oncol       Date:  2007-12-21       Impact factor: 3.402

2.  Prostate cryotherapy monitoring using vibroacoustography: preliminary results of an ex vivo study and technical feasibility.

Authors:  Farid G Mitri; Brian J Davis; Azra Alizad; James F Greenleaf; Torrence M Wilson; Lance A Mynderse; Mostafa Fatemi
Journal:  IEEE Trans Biomed Eng       Date:  2008-11       Impact factor: 4.538

3.  Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study.

Authors:  Ardeshir R Rastinehad; Harry Anastos; Ethan Wajswol; Jared S Winoker; John P Sfakianos; Sai K Doppalapudi; Michael R Carrick; Cynthia J Knauer; Bachir Taouli; Sara C Lewis; Ashutosh K Tewari; Jon A Schwartz; Steven E Canfield; Arvin K George; Jennifer L West; Naomi J Halas
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-26       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.